MC-VC-PABC-DNA31
Based on 1 Customer Validation
MC-VC-PABC-DNA31 is a agent-linker conjugate for ADC with potent antitumor activity by using DNA31 (a potent RNA polymerase inhibitor), linked via the ADC linker MC-VC-PABC.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 97.45%
- CAS No.: 1639352-03-6
- Formule: C77H96N10O21
- Masse moléculaire:1497.64
-
Stockage:
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-13631E
DeruxtecanDrug-Linker Conjugates for ADC -
HY-101141
sulfo-SPDB-DM4Drug-Linker Conjugate for ADC -
HY-13631EG
Deruxtecan (GMP)Drug-Linker Conjugates for ADC -
HY-19812
Acetylene-linker-Val-Cit-PABC-MMAEDrug-Linker Conjugate for ADC -
HY-101982
Lys-SMCC-DM1Drug-Linker Conjugates for ADC -
HY-12460
SPDB-DM4ADC Linker -
HY-128904
MC-Val-Cit-PAB-duocarmycin chlorideDrug-Linker Conjugate for ADC -
HY-128902
MC-Val-Cit-PAB-vinblastineDrug-Linker Conjugate for ADC -
HY-128906
MC-Val-Cit-PAB-RetapamulinDrug-Linker Conjugates for ADC -
HY-128908
MC-Val-Cit-PAB-IndibulinDrug-Linker Conjugates for ADC -
HY-128899
MC-Val-Cit-PAB-Auristatin EDrug-Linker Conjugates for ADC -
HY-128903
MC-Val-Cit-PAB-carfilzomib iodideDrug-Linker Conjugates for ADC
Voir tous les produits spécifiques à Isoform Drug-Linker Conjugates for ADC
More
Activité biologique
Description
IC50 & Target
|
Traditional Cytotoxic Agents |
Chemical Information
-
CAS No. 1639352-03-6
-
Appearance Solid
-
Masse moléculaire 1497.64
-
Formule C77H96N10O21
-
Color Light blue to blue
-
SMILES
O=C([C@H](CCCNC(N)=O)NC([C@H](C(C)C)NC(CCCCCN1C(C=CC1=O)=O)=O)=O)NC2=CC=C(COC(NC3CCN(C4=CC(OC(C5=N6)=C(NC(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O7)=O)C(C8=C(O)C(C)=C(O[C@@]7(C)C9=O)C9=C85)=O)=C6C(O)=C4)CC3)=O)C=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
4°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Solvant et solubilité
In Vitro:
DMSO : 50 mg/mL (33.39 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 3 mg/mL (2.00 mM); Clear solution; Need ultrasonic
This protocol yields a clear solution of 3 mg/mL.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 3 mg/mL (2.00 mM); Clear solution
This protocol yields a clear solution of ≥ 3 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (30.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureté et documentation
-
Fiche technique (271 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.6677 mL | 3.3386 mL | 6.6772 mL | 16.6929 mL |
| 5 mM | 0.1335 mL | 0.6677 mL | 1.3354 mL | 3.3386 mL | |
| 10 mM | 0.0668 mL | 0.3339 mL | 0.6677 mL | 1.6693 mL | |
| 15 mM | 0.0445 mL | 0.2226 mL | 0.4451 mL | 1.1129 mL | |
| 20 mM | 0.0334 mL | 0.1669 mL | 0.3339 mL | 0.8346 mL | |
| 25 mM | 0.0267 mL | 0.1335 mL | 0.2671 mL | 0.6677 mL | |
| 30 mM | 0.0223 mL | 0.1113 mL | 0.2226 mL | 0.5564 mL |
MC-VC-PABC-DNA31 Related Classifications
HY-128897 Related Classifications
Powered by Bioz